Is 4D Molecular Therapeutics, Inc. (FDMT) a Buy, Sell, or Hold?
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$11.7 USD
$0.4 (3.54%)
- Volume
- 651.78K
- Average Volume
- 872.77K
- Market Capitalization
- $611.63M
- P/E Ratio
- -4.40
- Dividend Yield
- 0.00%
- Price Target
- $33.00
- Year High
- $14.00
- Year Low
- $4.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.34
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-64.5% DOWNSIDE
$33.00 Price Target
UPSIDE/DOWNSIDE HIGH
-64.5% DOWNSIDE
$33.00 Price Target High
UPSIDE/DOWNSIDE LOW
-64.5% DOWNSIDE
$33.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Barclays | Gena Wang | $33 | $10.17 | 2025-11-11 05:23 AM | 224.5% |
| Leerink Partners | Mani Foroohar | $17 | $11.4986 | 2025-10-31 09:20 AM | 47.8% |
| RBC Capital | Lisa Walter | $26 | $10.765 | 2025-10-21 09:11 AM | 141.5% |
| Morgan Stanley | Judah Frommer | $6 | $5.52 | 2025-01-11 02:38 PM | 8.7% |
| BMO Capital | Kostas Biliouris | $40 | $13.28 | 2024-09-19 04:14 AM | 201.2% |
| Loop Capital Markets | Geulah Livshits | $39 | $13.3112 | 2024-09-19 04:06 AM | 193.0% |
| H.C. Wainwright | Matthew Caufield | $36 | $13.3118 | 2024-09-19 02:46 AM | 170.4% |
| RBC Capital | Lisa Walter | $40 | $26.35 | 2024-04-15 02:29 AM | 51.8% |
| Barclays | Gena Wang | $45 | $26.35 | 2024-04-14 11:43 PM | 70.8% |